These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36773115)

  • 1. Global Pull Incentives for Better Antibacterials: The UK Leads the Way.
    Outterson K; Rex JH
    Appl Health Econ Health Policy; 2023 May; 21(3):361-364. PubMed ID: 36773115
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicines.
    Outterson K
    Health Aff (Millwood); 2021 Nov; 40(11):1758-1765. PubMed ID: 34724432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pull incentives for antibiotics get push from the UK.
    Mullard A
    Nat Rev Drug Discov; 2022 Jun; 21(6):406. PubMed ID: 35538235
    [No Abstract]   [Full Text] [Related]  

  • 4. Can the UK 'Netflix' Payment Model Boost the Antibacterial Pipeline?
    Leonard C; Crabb N; Glover D; Cooper S; Bouvy J; Wobbe M; Perkins M
    Appl Health Econ Health Policy; 2023 May; 21(3):365-372. PubMed ID: 36646872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reimbursement models to tackle market failures for antimicrobials: Approaches taken in France, Germany, Sweden, the United Kingdom, and the United States.
    Gotham D; Moja L; van der Heijden M; Paulin S; Smith I; Beyer P
    Health Policy; 2021 Mar; 125(3):296-306. PubMed ID: 33402265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.
    Årdal C; Røttingen JA; Opalska A; Van Hengel AJ; Larsen J
    Clin Infect Dis; 2017 Oct; 65(8):1378-1382. PubMed ID: 29017240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of UK provider financial incentives on quality of care: a systematic review.
    Mandavia R; Mehta N; Schilder A; Mossialos E
    Br J Gen Pract; 2017 Nov; 67(664):e800-e815. PubMed ID: 28993305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All.
    Bhatti T; Lum K; Holland S; Sassman S; Findlay D; Outterson K
    J Law Med Ethics; 2018 Jun; 46(1_suppl):59-65. PubMed ID: 30146959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial incentives for bowel cancer screening: Results from a mixed methods study in the United Kingdom.
    Wilding S; O'Connor DB; Conner M
    Br J Health Psychol; 2022 Sep; 27(3):741-755. PubMed ID: 34747113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe.
    Årdal C; Lacotte Y; Ploy MC
    Clin Infect Dis; 2020 Nov; 71(8):1994-1999. PubMed ID: 32060511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMR - UK is leading the rest of the world.
    Waters A
    Vet Rec; 2019 Mar; 184(10):297. PubMed ID: 30846620
    [No Abstract]   [Full Text] [Related]  

  • 12. Mental health and the response to financial incentives: Evidence from a survey incentives experiment.
    Kung CSJ; Johnston DW; Shields MA
    J Health Econ; 2018 Nov; 62():84-94. PubMed ID: 30326369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective antibacterials: at what cost? The economics of antibacterial resistance and its control.
    White AR;
    J Antimicrob Chemother; 2011 Sep; 66(9):1948-53. PubMed ID: 21700625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of financial incentives for breastfeeding: thematic analysis of readers' comments to UK online news reports.
    Giles EL; Holmes M; McColl E; Sniehotta FF; Adams JM
    BMC Pregnancy Childbirth; 2015 May; 15():116. PubMed ID: 25982305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance.
    Sciarretta K; Røttingen JA; Opalska A; Van Hengel AJ; Larsen J
    Clin Infect Dis; 2016 Dec; 63(11):1470-1474. PubMed ID: 27578820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic Development Incentives That Reflect Societal Value of Antibiotics.
    Boucher HW; File TM; Fowler VG; Jezek A; Rex JH; Outterson K
    Clin Infect Dis; 2021 May; 72(9):e420-e421. PubMed ID: 31999818
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic treatment for gonorrhoea in the UK.
    Fitzgerald M
    Genitourin Med; 1997 Apr; 73(2):149. PubMed ID: 9215110
    [No Abstract]   [Full Text] [Related]  

  • 18. Public acceptability of financial incentives to reward pregnant smokers who quit smoking: a United Kingdom-France comparison.
    Berlin N; Goldzahl L; Bauld L; Hoddinott P; Berlin I
    Eur J Health Econ; 2018 Jun; 19(5):697-708. PubMed ID: 28646249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethics of setting national antibiotic policies using financial incentives.
    Li G; Hooper C; Papanikitas A; Hopkins S; Sharland M
    Br J Gen Pract; 2017 Sep; 67(662):419-420. PubMed ID: 28860299
    [No Abstract]   [Full Text] [Related]  

  • 20. UK antibiotic reductions begin to plateau.
    Vet Rec; 2020 Nov; 187(11):424. PubMed ID: 33247031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.